Back

From Past to Present: Pompe Disease, Pseudodeficiency Alleles, and Diagnostic Challenges

Giliberto, F.; Buonfiglio, P. I.; Capellino, G.; Massini, C. L.; Dalamon, V.; Luce, L.; Carcione, M.

2024-10-04 genetic and genomic medicine
10.1101/2024.10.03.24314698 medRxiv
Show abstract

Pompe disease is an autosomal recessive disorder caused by GAA variants leading to acid alpha-glucosidase deficiency. Diagnosis is challenging due to the variable phenotypic presentation and overlap with other conditions. Traditionally, diagnosis relies on measuring enzyme activity, but next-generation sequencing (NGS) advancements have improved accuracy. However, interpreting variants is complex, especially because pseudodeficiency alleles mimic disease-causing variants. We present two patients harboring the pseudodeficiency allele NM_000152.5(GAA):c.271G>A, p.Asp91Asn, which is confusing due to inaccurate reports and results related to enzymatic activity. The first case was a recently published controversial case of a 700-year-old mummy in which the authors classified the variant as pathogenic. The second patient had symptoms compatible with late-onset Pompe disease and was homozygous for the variant. We aimed to determine the correct variant classification using GAA:c.271G>A as a model and to achieve a genetic diagnosis of the second patient. This variant was analyzed following international guidelines (ACMG-AMP) and reviewed with the Lysosomal Diseases Variant Curation Expert Panel. The second patient underwent NGS. We demonstrated that GAA:c.271G>A meets the criterion of being classified as benign for Pompe. Additionally, the second patient carried a heterozygous pathogenic PABPN1 variant associated with oculopharyngeal muscular dystrophy, which better explained the clinical features. This underscores the importance of expanding the genetic analysis in the presence of pseudodeficiency alleles that can mask the true cause of the disease and highlights the fact that an accurate diagnosis should adhere to guidelines on variant curation to reduce the risk of misdiagnosis, which could result in inadequate care and risky medical decisions. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=84 SRC="FIGDIR/small/24314698v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@12a720borg.highwire.dtl.DTLVardef@1a53d15org.highwire.dtl.DTLVardef@14d4729org.highwire.dtl.DTLVardef@7b0186_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Human Mutation
29 papers in training set
Top 0.1%
23.8%
2
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.1%
10.7%
3
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.1%
7.2%
4
Human Molecular Genetics
130 papers in training set
Top 0.4%
5.1%
5
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.1%
4.2%
50% of probability mass above
6
The American Journal of Human Genetics
206 papers in training set
Top 1%
2.9%
7
Genetics in Medicine
69 papers in training set
Top 0.5%
2.9%
8
Muscle & Nerve
10 papers in training set
Top 0.1%
2.2%
9
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.0%
10
Journal of Medical Genetics
28 papers in training set
Top 0.2%
2.0%
11
The Journal of Molecular Diagnostics
36 papers in training set
Top 0.2%
1.8%
12
Movement Disorders
62 papers in training set
Top 0.6%
1.8%
13
npj Genomic Medicine
33 papers in training set
Top 0.4%
1.6%
14
European Journal of Human Genetics
49 papers in training set
Top 0.8%
1.3%
15
Scientific Reports
3102 papers in training set
Top 67%
1.2%
16
Neurobiology of Disease
134 papers in training set
Top 3%
1.0%
17
Frontiers in Neurology
91 papers in training set
Top 4%
1.0%
18
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.8%
19
JCI Insight
241 papers in training set
Top 7%
0.8%
20
The Journal of Pediatrics
15 papers in training set
Top 0.6%
0.8%
21
Neurology
44 papers in training set
Top 1%
0.8%
22
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
0.8%
23
Human Genetics and Genomics Advances
70 papers in training set
Top 0.7%
0.8%
24
Journal of Cachexia, Sarcopenia and Muscle
27 papers in training set
Top 0.3%
0.8%
25
Genome Medicine
154 papers in training set
Top 8%
0.8%
26
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
27
Frontiers in Molecular Biosciences
100 papers in training set
Top 5%
0.8%
28
European Journal of Neurology
20 papers in training set
Top 0.6%
0.8%
29
Human Genomics
21 papers in training set
Top 0.3%
0.8%
30
Frontiers in Genetics
197 papers in training set
Top 11%
0.7%